Advertisement

Virologica Sinica

, Volume 24, Issue 2, pp 121–135 | Cite as

The role of the charged residues of the GP2 helical regions in Ebola entry

  • Haiqing Jiang
  • Jizhen Wang
  • Balaji Manicassamy
  • Santhakumar Manicassamy
  • Michael Caffrey
  • Lijun RongEmail author
Article

Abstract

The glycoprotein (GP) of Ebola is the sole structural protein that forms the spikes on the viral envelope. The GP contains two subunits, GP1 and GP2, linked by a disulfide bond, which are responsible for receptor binding and membrane fusion, respectively. In this study, the full length of GP gene of Ebola Zaire species, 2028 base pairs in length, was synthesized using 38 overlapping oligonucleotides by multiple rounds of polymerase chain reaction (PCR). The synthesized GP gene was shown to be efficiently expressed in mammalian cells. Furthermore, an efficient HIV-based pseudotyping system was developed using the synthetic GP gene, providing a safe approach to dissecting the entry mechanism of Ebola viruses. Using this pseudotyping system and mutational analysis, the role of the charged residues in the GP2 helical regions was examined. It was found that substitutions of the most charged residues in the regions did not adversely affect GP expression, processing, or viral incorporation, however, most of the mutations greatly impaired the ability of GP to mediate efficient viral infection. These results demonstrate that these charged residues of GP2 play an important role in GP-mediated Ebola entry into its host cells. We propose that these charged residues are involved in forming the intermediate conformation(s) of GP in membrane fusion and Ebola entry.

Key words

Ebola virus Glycoprotein GP1/GP2 Charged residues Viral entry 

CLC number

Q939.4 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bachelder R E, Bilancieri J, Lin W,et al. 1995. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J Virol, 69:5734–5742.PubMedGoogle Scholar
  2. 2.
    Baker K A, Dutch R E, Lamb R A,et al. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell, 3:309–319.CrossRefPubMedGoogle Scholar
  3. 3.
    Bisht H, Roberts A, Vogel L,et al. 2004. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA, 101:6641–6646.CrossRefPubMedGoogle Scholar
  4. 4.
    Brindley M A, Hughes L, Ruiz A,et al. 2007. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol, 81:7702–7709.CrossRefPubMedGoogle Scholar
  5. 5.
    Bullough P A, Hughson F M, Skehel J J,et al. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature, 371:37–43.CrossRefPubMedGoogle Scholar
  6. 6.
    Caffrey M. 2001. Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop. Biochim Biophys Acta, 1536:116–122.PubMedGoogle Scholar
  7. 7.
    Carr C M, Kim P S. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell, 73:823–832.CrossRefPubMedGoogle Scholar
  8. 8.
    Colman P M, Lawrence M C. 2003. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol, 4:309–319.CrossRefPubMedGoogle Scholar
  9. 9.
    Connor R I, Chen B K, Choe S,et al. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology, 206:935–944.CrossRefPubMedGoogle Scholar
  10. 10.
    Fass D, Blacklow S C, Kim P S. 1996. Retrovirus envelope domain at 1.7A0 resolution. Nature Struct Biol, 3:465–469.CrossRefPubMedGoogle Scholar
  11. 11.
    Gallaher W R. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell, 85:477–478.CrossRefPubMedGoogle Scholar
  12. 12.
    Higginbottom A, Quinn E R, Kuo C C,et al. 2000. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 [In Process Citation]. J Virol, 74:3642–3649.CrossRefPubMedGoogle Scholar
  13. 13.
    Jeffers S A, Sanders D A, Sanchez A. 2002. Covalent modifications of the ebola virus glycoprotein. J Virol, 76:12463–12472.CrossRefPubMedGoogle Scholar
  14. 14.
    Kao C C, Yang X, Kline A,et al. 2000. Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase. J Virol, 74:11121–11128.CrossRefPubMedGoogle Scholar
  15. 15.
    Kuhn J H, Radoshitzky S R, Guth A C,et al. 2006. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem, 281:15951–15958.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee J E, Fusco M L, Hessell A J,et al. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature, 454:177–182.CrossRefPubMedGoogle Scholar
  17. 17.
    Ma M, Kersten D B, Kamrud K I,et al. 1999. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Res, 64:23–32.CrossRefPubMedGoogle Scholar
  18. 18.
    Malashkevich V N, Chan D C, Chutkowski C T,et al. 1998. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci U S A, 95:9134–9139.CrossRefPubMedGoogle Scholar
  19. 19.
    Malashkevich V N, Schneider B J, McNally M L,et al. 1999. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci USA, 96:2662–2667.CrossRefPubMedGoogle Scholar
  20. 20.
    Manicassamy B, Wang J, Jiang H,et al. 2005. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry. J Virol, 79:4793–4805.CrossRefPubMedGoogle Scholar
  21. 21.
    Manicassamy B, Wang J, Rumschlag E,et al. 2007. Characterization of Marburg virus glycoprotein in viral entry. Virology, 358:79–88.CrossRefPubMedGoogle Scholar
  22. 22.
    Medina M F, Kobinger G P, Rux J,et al. 2003. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther, 8:777–789.CrossRefPubMedGoogle Scholar
  23. 23.
    Mpanju O M, Towner J S, Dover J E,et al. 2006. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res, 121:205–214.CrossRefPubMedGoogle Scholar
  24. 24.
    Neumann G, Feldmann H, Watanabe S,et al. 2002. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol, 76:406–410.CrossRefPubMedGoogle Scholar
  25. 25.
    Prehaud C, Hellebrand E, Coudrier D,et al. 1998. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol, 79(Pt 11):2565–2572.PubMedGoogle Scholar
  26. 26.
    Rong L, Bates P. 1995. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry. J Virol, 69:4847–4853.PubMedGoogle Scholar
  27. 27.
    Rong L, Gendron K, Strohl B,et al. 1998. Characterization of determinants for envelope binding and infection in Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol, 72:4552–4559.PubMedGoogle Scholar
  28. 28.
    Russell C J, Kantor K L, Jardetzky T S,et al. 2003. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol, 163:363–374.CrossRefPubMedGoogle Scholar
  29. 29.
    Sanchez A, Khan A S, Zaki S R,et al. 2001. Filoviridae: Marburg and Ebola Viruses. In: Fields Virology (Knipe D M, Howley P M. ed.), 4th ed, vol. 1. Lippicott Williams & Wilkins, Philadelphia, PA. p1279–1304.Google Scholar
  30. 30.
    Sanchez A, Kiley M P, Holloway B P,et al. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res, 29:215–240.CrossRefPubMedGoogle Scholar
  31. 31.
    Sanchez A, Trappier S G, Mahy B W,et al. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci USA, 93:3602–3607.CrossRefPubMedGoogle Scholar
  32. 32.
    Sanchez A, Trappier S G, Stroher U,et al. 1998. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology, 240:138–146.CrossRefPubMedGoogle Scholar
  33. 33.
    Simmons G, Wool-Lewis R J, Baribaud F,et al. 2002. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol, 76:2518–2528.CrossRefPubMedGoogle Scholar
  34. 34.
    Takada A, Feldmann H, Stroeher U,et al. 2003. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol, 77:1069–1074.CrossRefPubMedGoogle Scholar
  35. 35.
    Takada A, Robison C, Goto H,et al. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA, 94:14764–14769.CrossRefPubMedGoogle Scholar
  36. 36.
    Volchkov V E, Becker S, Volchkova V A,et al. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology, 214:421–430.CrossRefPubMedGoogle Scholar
  37. 37.
    Volchkov V E, Blinov V M, Netesov S V. 1992. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett, 305:181–184.CrossRefPubMedGoogle Scholar
  38. 38.
    Weissenhorn W, Dessen A, Harrison S C,et al. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387:426–430.CrossRefPubMedGoogle Scholar
  39. 39.
    Weissenhorn W, Calder L J, Wharton S A,et al. 1998. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci USA, 95:6032–6036.CrossRefPubMedGoogle Scholar
  40. 40.
    Wilson I A, Skehel J J, Wiley D C. 1981. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3A resolution. Nature, 289:366–373.CrossRefPubMedGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag GmbH 2009

Authors and Affiliations

  • Haiqing Jiang
    • 1
  • Jizhen Wang
    • 1
  • Balaji Manicassamy
    • 1
  • Santhakumar Manicassamy
    • 1
  • Michael Caffrey
    • 2
  • Lijun Rong
    • 1
    Email author
  1. 1.Department of Microbiology and Immunology, College of MedicineUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Department of Biochemistry and Molecular GeneticsUniversity of Illinois at Chicago College of MedicineChicagoUSA

Personalised recommendations